Insulin binding to human B lymphoblasts is a function of HLA haplotype

Area of Science:

• Immunogenetics
• Molecular Endocrinology
• Cell Biology

Background:

• Genetic and biochemical studies suggest a link between Major Histocompatibility Complex (MHC) haplotypes and cell surface receptors like insulin receptors.
• Human Leukocyte Antigen (HLA) antigens, part of the MHC, are known to play roles in immune responses and cellular interactions.
• Understanding the regulation of insulin receptors is crucial for metabolic research and understanding conditions like diabetes.

Purpose of the Study:

• To investigate the association between specific human class I MHC antigens (HLA antigens) and insulin binding sites on human B lymphoblasts.
• To determine if variations in HLA antigen expression affect the affinity of insulin binding to B lymphoblast cell lines.

Main Methods:

• Utilized an Epstein-Barr virus-transformed B-cell line (LCL 721) and its derivative mutants lacking parts or all of the HLA complex.
• Quantified insulin binding affinity (Ka) to these cell lines using radioligand binding assays.
• Correlated insulin binding affinity with the presence or absence of specific HLA antigens (e.g., HLA-A, HLA-B, HLA-C).

Main Results:

• Insulin binding affinity was approximately 10^8 M^-1 in mutants expressing HLA-B5 or HLA-C antigens.
• Mutants expressing HLA-A1, HLA-A1/B8, HLA-A2/C, or lacking HLA antigens (null mutants) exhibited a higher insulin binding affinity of approximately 10^9 M^-1.
• The presence and specific type of HLA antigens significantly modulated the affinity of insulin binding sites on B lymphoblasts.

Conclusions:

• Specific human class I MHC (HLA) antigens are associated with distinct insulin binding affinities on B lymphoblasts.
• The findings provide evidence for a functional link between the immune system's MHC and insulin receptor regulation.
• This association may have implications for understanding immune-mediated effects on metabolic regulation.